The DOI matches its Crossref record.
ALUMINIUM, NEUROFIBRILLARY DEGENERATION AND ALZHEIMER'S DISEASE
Abstract
Aluminium is neurotoxic and results in the proliferation of 100 A diameter filaments in the cytoplasm of certain neurons. The aluminium concentration for 7 normal human brains was 1-9 +/- 0-7 SD mug/g dry weight (n = 208 samples). The aluminium content of 585 areas sampled in 10 post-mortem cases of Alzheimer's disease ranging in age from 50 to 88 years, in which the diagnosis was based on the specific histological appearances, revealed an elevated aluminium content in some regions. A range of 0-4 - 107-0 mug/g was encountered and 28 per cent of all regions sampled had concentrations in excess of 4 mug/g. Five of 6 cerebral biopsies from patients with Alzheimer's disease also had elevated aluminium content. In 2 additional Alzheimer's brains with neurofibrillary degeneration restricted to certain anatomical areas, elevated aluminium content was found to be associated with neurofibrillary degeneration and not with senile plaques. Furthermore, elevated aluminium content in multiple cortical regions was not found in 2 vascular dementias of the elderly. While the cytotoxic concentration for human neurons is unknown, the cytotoxic concentration for cat's cerebral neurons appears to lie between 4 and 6 mug/g dry weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., & Rondeau, V. (2007) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701597766 · Cited by 998
Perl, D. P., & Brody, A. R. (1980) · Science · doi:10.1126/science.7367858 · Cited by 993
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724
(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 499
Metabolism and possible health effects of aluminum.
Ganrot, P. O. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665363 · Cited by 483
Good, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476
Alzheimer's disease in Down's syndrome: Clinicopathologic studies
Wisniewski, K. E., Dalton, A. J., McLachlan, D. R. C., Wen, G. Y., & Wisniewski, H. M. (1985) · Neurology · doi:10.1212/wnl.35.7.957 · Cited by 417
Gastrointestinal Absorption of Aluminum from Aluminum-Containing Antacids
Kaehny, W. D., Hegg, A. P., & Alfrey, A. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706162962407 · Cited by 398
Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link?
Tomljenovic, L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101494 · Cited by 370
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
Barnard, N. D., Bush, A. I., Ceccarelli, A., Cooper, J., de Jager, C. A., Erickson, K. I., Fraser, G., Kesler, S., Levin, S. M., Lucey, B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.033 · Cited by 339
Glutamate dysfunction in Alzheimer's disease: an hypothesis
Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 334
Epidemiology of clinically diagnosed Alzheimer's disease
Rocca, W. A., Amaducci, L. A., & Schoenberg, B. S. (1986) · Annals of Neurology · doi:10.1002/ana.410190502 · Cited by 288
Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia
Wisniewski, K., Jervis, G. A., Moretz, R. C., & Wisniewski, H. M. (1979) · Annals of Neurology · doi:10.1002/ana.410050311 · Cited by 281
Metabolism and toxicity of aluminum in renal failure
Alfrey, A. C., Hegg, A., & Craswell, P. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.7.1509 · Cited by 278
Aluminum Forms in Drinking Water and Risk of Alzheimer's Disease
Gauthier, E., Fortier, I., Courchesne, F., Pepin, P., Mortimer, J., & Gauvreau, D. (2000) · Environmental Research · doi:10.1006/enrs.2000.4101 · Cited by 252
Aluminium content of foods and diets
Pennington, J. A. T. (1988) · Food Additives and Contaminants · doi:10.1080/02652038809373696 · Cited by 148
Kasarskis, E. J., Tandon, L., Lovell, M. A., & Ehmann, W. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00037-3 · Cited by 145
Mann, D. M. A. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90100-8 · Cited by 135
The Clinical Biochemistry of Aluminum
King, S. W., Savory, J., Wills, M. R., & Gitelman, H. J. (1981) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368109105861 · Cited by 105
Dementia in the Elderly: The Silent Epidemic
BECK, J. C., BENSON, D. F., SCHEIBEL, A. B., SPAR, J. E., & RUBENSTEIN, L. Z. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-2-231 · Cited by 97
Amyotrophic lateral sclerosis: toxins and environment
Mitchell, J. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515061 · Cited by 87
A unifying hypothesis of alzheimer’s disease: III—Risk factors
Heininger, K. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(200001)15:1<1::aid-hup153>3.0.co;2-1
Metadata
- Authors
- CRAPPER, D. R., KRISHNAN, S. S., & QUITTKAT, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1976
- Volume
- 99
- Issue
- 1
- Pages
- 67-80
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2054417790
- Cited by
- 451
- References
- 0
- FWCI
- 22.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.